Tubulin Colchicine Binding Site Inhibitors as Vascular Disrupting Agents in Clinical Developments

E-ISSN： 1875-533x|22|11|1348-1360

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.22, Iss.11, 2015-04, pp. : 1348-1360

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Recent Development and SAR Analysis of Colchicine Binding Site Inhibitors

Mini Reviews in Medicinal Chemistry, Vol. 9, Iss. 10, 2009-09 ,pp. : 1174-1190

Bentham Science Publishers

Access to resources Recommend Favorite

Angiogenesis Inhibitors and Vascular Disrupting Agents in Non-Small Cell Lung Cancer

Current Medicinal Chemistry, Vol. 16, Iss. 30, 2009-01 ,pp. : 3919-3930

Bentham Science Publishers

Access to resources Recommend Favorite

Small-molecule, tubulin-binding compounds as vascular targeting agents

By Marx Matthew A

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 6, 2002-06 ,pp. : 769-776

Informa Healthcare

Access to resources Recommend Favorite

Vascular-disrupting agents in oncology

By Mita Monica M Sargsyan Liza Mita Alain C Spear Matt

Expert Opinion on Investigational Drugs, Vol. 22, Iss. 3, 2013-03 ,pp. : 317-328

Informa Healthcare

Access to resources Recommend Favorite

3D QSAR studies for the -tubulin binding site of microtubule-stabilizing anticancer agents (MSAAs) - A pseudoreceptor model for taxanes based on the experimental structure of tubulin

By Maccari L. Manetti F. Corelli F. Botta M.

Il Farmaco, Vol. 58, Iss. 9, 2003-09 ,pp. : 659-668

Elsevier

Access to resources Recommend Favorite